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Background: A growing number of clinical and basic research studies have implicated immunological
abnormalities as being associated with and potentially responsible for the cognitive and behavioral deficits seen in
autism spectrum disorder (ASD) children. Here we test the hypothesis that immune-related gene loci are associated
with ASD.
Findings: We identified 2,012 genes of known immune-function via Ingenuity Pathway Analysis. Family-based tests
of association were computed on the 22,904 single nucleotide polymorphisms (SNPs) from the 2,012 immune-
related genes on 1,510 trios available at the Autism Genetic Resource Exchange (AGRE) repository. Several SNPs in
immune-related genes remained statistically significantly associated with ASD after adjusting for multiple
comparisons. Specifically, we observed significant associations in the CD99 molecule-like 2 region (CD99L2,
rs11796490, P= 4.01 × 10-06, OR = 0.68 (0.58-0.80)), in the jumonji AT rich interactive domain 2 (JARID2) gene
(rs13193457, P= 2.71 × 10-06, OR = 0.61 (0.49-0.75)), and in the thyroid peroxidase gene (TPO) (rs1514687,
P= 5.72 × 10-06, OR = 1.46 (1.24-1.72)).
Conclusions: This study suggests that despite the lack of a general enrichment of SNPs in immune function genes
in ASD children, several novel genes with known immune functions are associated with ASD.
Keywords: Autism Spectrum Disorders, immune loci, family-based association analysis, single-nucleotide
polymorphismFindings
Background
Autism spectrum disorders (ASDs) encompass a hetero-
geneous group of clinical descriptors whose core fea-
tures include deficits in cognition, communication and
social acuity, coupled with stereotypical behaviors. Cur-
rently, 1 in 88 children in the United States have an
ASD diagnosis, with boys being affected at a ratio of 5:1
compared to girls [1]. The etiology of ASDs, with very
few exceptions, is unknown although a growing number
of clinical and basic research studies have implicated im-
munological abnormalities as being associated with and
potentially responsible for the cognitive and behavioral
deficits seen in ASD children [2-4].
A judicious and efficient way to identify genetic vari-
ation predisposing to complex diseases is the application* Correspondence: swalker@wakehealth.edu
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reproduction in any medium, provided the orof a hypothesis-driven framework that incorporates prior
biological knowledge. Unlike agnostic genome wide as-
sociation studies (GWAS), this approach narrows the
hypothesis space to provide a more focused and power-
ful examination of the data. Indeed, several studies have
shown that a hypothesis-driven approach of selecting
candidate genes serves to increase the reliability and
likelihood of finding genes that are truly associated with
disease [5,6]. In accord with these considerations, we
tested for associations between immune-related genes
and ASD children.
Approach
We used Ingenuity Pathway Analysis (IPA) [7], a bio-
informatics database, to search for molecules with
known immune function. IPA offers the largest and most
comprehensive set of functional annotations, integrating
manually curated data from other databases, and a broad
range of scientific literature. Briefly, we searched for “im-
mune” under Functions and Diseases, exported theLtd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the positions of the corresponding 2,012 immune-func-
tion genes (Additional file 1: Table S1).
We then used the genotypic data available at the Autism
Genetic Resource Exchange (AGRE) [9] repository to per-
form a family-based association analysis between variants
in those 2,012 immune loci and ASD. These data have
previously been used in several GWAS [10-12], and the
families used in our analysis are, with the exception of
minor differences due to slightly different quality control
criteria, the same ones as reported in Ma et al. [10], Wang
et al. [11] and Weiss et al. [12]. These data and families
also overlap with those reported by Voineagu et al. [13],
who, included in their expression profiling study, used the
AGRE data to perform an analysis searching for evidence
of a genetic enrichment of immune loci. We searched for
SNPs in a region including 5 kb up- and downstream of
each immune gene. After applying quality control filters,
we identified 22,904 SNPs genotyped in the AGRE collec-
tion of 1,510 trios on the Illumina Hap550 platform. We
tested these SNPs for association with ASD using the
standard Transmission Disequilibrium Test (TDT), as
implemented in PLINK v1.07 [14]. In addition, given that
the 1,510 trios are part of 1,057 independent nuclear fam-
ilies, we also used the Pedigree Disequilibrium Test
(PDT), which uses data from related nuclear families and
discordant sibships from extended pedigrees [15]. The fol-
lowing exclusion filters were applied: minor allele
frequency (MAF)< 0.01, SNP genotyping missing rate
> 10%, individuals> 10% missing genotypes, Hardy-
Weinberg Equilibrium (HWE) P-value< 0.001 (founders),
Mendelian error rate> 5% per family and> 4% per SNP.
Since we hypothesized that ASD children may be
enriched for risk loci in immune genes, we tested for a
potential enrichment of significant P-values for SNPs in
immune-related genes. We tested for an enrichment of
association signals in these genes using INRICH [16],
which corrects the empirical gene-set P-value using
Bootstrapping-based re-sampling. In addition, we
assessed the distribution of the linkage-disequilibrium





rs7880807I X 15.006 CD99L2 A 190:
rs13193457* 6 15.346 JARID2 A 139:
rs11796490 X 150.058 CD99L2 G 239:
rs1514687 2 1.438 TPO A 349:
rs10890518I 2 1.435 TPO G 356:
Chr, Chromosome; Pos., position; MA, minor allele; T:U, transmitted to untransmitted
Discovery Rate-adjusted P-value; ND, test not done with imputed data; NA, not app
Mendelian error rate. IThis SNP was imputed.SNPs, using an r2> 0.2 for LD-based SNP pruning. We
did not observe an enrichment of immune-gene associa-
tions with either test (P= 1.0 and P= 0.45, respectively).
In order to adjust for multiple testing we applied a
Benjamini and Hochberg false discovery rate (FDR) cor-
rection [17] to the 22,904 SNPs analyzed (P-FDR). Only
three SNPs remained statistically significant (P-FDR
< 0.05) (Table 1). Under an additive model, and at
alpha = 1.0E-05, this sample has >80% power to detect
the associations reported in Table 1.
Finally, in order to fine map the novel loci, we used
BEAGLE v3.3.2 [18] and the 1000 Genomes Project
Phase 1 (version 3; http://www.1000genomes.org/) refer-
ence panel to impute all SNPs in the regions of the top
genes.
Novel immune genes
The lack of an enrichment of significant associations in
immune genes corroborates the findings by Voineagu
et al. [13], who used a complimentary approach to test for
evidence of a genetic component for the up-regulation of
immune response genes in the autistic brain using the
same AGRE genotype data. Nevertheless, we uncovered a
few associations in immune-related genes that met an
FDR-adjustment.
We observed a significant association in the CD99
molecule-like 2 gene (CD99L2) (rs11796490, P=4.01x10-06,
OR=0.68 (0.58-0.80)) (Table 1). An imputed variant in LD
with this genotyped SNP showed even stronger association
(rs7880807, P=8.26 x 10-07, OR=0.64 (0.53-0.76)) (r2 =1.0
in CEU from HapMap release 21) (Figure 1). As is evident
from Figure 1, other variants in this gene are also showing
evidence of association with ASD. Although more modest,
these associations with neighboring SNPs corroborate the
association observed at rs11796490, which is, therefore, less
likely to be spurious. This variant is located in the first in-
tron of CD99L2. The product of this gene functions as an
adhesion molecule during leukocyte extravasation, in par-
ticular at the diapedesis step.
A variant in the first intron of the jumonji AT rich
interactive domain 2 (JARID2) gene showed associationalyses
PDT
OR (95% CI) P-value P-FDR P-value
299 0.64 (0.53-0.76) 8.26E-07 - ND
229 0.61 (0.49-0.75) 2.71E-06 - 6.04E-05
351 0.68 (0.58-0.80) 4.01E-06 1.53E-02 NA
239 1.46 (1.24-1.72) 5.72E-06 1.87E-02 4.49E-06
249 1.43 (1.22-1.62) 1.36E-05 - ND
minor allele counts; OR, odds ratio; CI, confidence interval; P-FDR. False
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Figure 1 Regional plots of immune ASD loci. Genotyped (circles) and imputed (triangles) SNPs are plotted with their P-values (as -log10 values)
as a function of genomic position (Human Genome Build 18) within a region surrounding the most significant SNP (purple color). Recombination
rates from the HapMap Phase II CEU are plotted in blue to reflect the regional LD structure. In each region, the index SNP is represented by a
large purple symbol, and the color of all other SNPs indicates LD with the index SNP based on pairwise r2 values from HapMap CEU (red, r2> 0.8;
orange, r2 = 0.6 to 0.8; green, r2 = 0.4 to 0.6; light blue, r2 = 0.2 to 0.4; dark blue, r2< 0.2). Known human genes in the UCSC Genome Browser are
in the bottom.
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0.75) (Table 1). Despite having a borderline Mendelian
error rate, this SNP is of interest. This gene has been
previously implicated in schizophrenia [19,20] and, more
recently, it has been reported in a GWAS for ASD that
also included the same AGRE dataset herein used [12].
The variant reported by Weiss et al. (rs7766973) does not
show LD with rs13193457 (r2 = 0.13 in CEU from 1000
Genomes Pilot 1). The jumonji-domain functions by re-
moving methyl marks on histones that are associated with
gene regulation [21]. JARID2 is required for neural tube
formation and is essential for normal heart development
and function, as well as acting as a transcriptional repres-
sor of ANF by binding to both GATA4 and NKX2-5 and
repressing their transcriptional activator activities.
An intronic variant in the thyroid peroxidase gene
(TPO) has also shown association with ASD (rs1514687,
P= 5.72 × 10-06, OR= 1.46 (1.24-1.72)). This association
is corroborated by those of neighboring SNPs (Figure 1).
This gene has been associated with hypothyroidism [22].
This gene encodes a membrane-bound glycoprotein
which acts as an enzyme and plays a central role in thy-
roid gland function. The protein functions in the iodin-
ation of tyrosine residues in thyroglobulin and phenoxy-
ester formation between pairs of iodinated tyrosines to
generate the thyroid hormones, thyroxine and triiodo-
thyronine. Mutations in this gene are associated with
several disorders of thyroid hormonogenesis, including
congenital hypothyroidism, congenital goiter and thyroid
hormone organification defect IIA. Multiple transcript
variants encoding distinct isoforms have been identified
for this gene.Discussion
In spite of its reported high heritability, the identification
of genetic risk factors predisposing to ASDs has been
difficult. To date, only a small number of loci are con-
sidered established (that is, have met genome-wide sig-
nificance and have been replicated in independent
cohorts). GWAS are by design agnostic. Increased statis-
tical power can be achieved with more focused hypoth-
eses. Given the increasing speculation of a significant
role for immune genes in the etiology and pathogenesis
of ASD, we undertook a search for genetic variation
associated with ASD in genes with immune functions.
This hypothesis-driven candidate gene approach based
on prior knowledge was selected because it serves to in-
crease the power, reliability and likelihood of finding
genes that are associated with disease [5,6].
A lack of enrichment of genetic associations in im-
mune-related genes has recently been reported [13] in
the same dataset we used, and this conclusion is sup-
ported here using another statistical approach. The asso-
ciations we uncovered in immune-related genes and the
observed dysregulation of immune genes in ASD [13]
suggest that variation in a limited number of immune-
function genes may be responsible for observed up-regu-
lation of their immune downstream targets.
The transmission/disequilibrium test (TDT) is
largely robust to population substructure as it is a
within-family comparison. The individuals in these
data are predominately of European descent (76%),
with Asian (3%) and African (2%) ancestry repre-
sented; the Autism Genetic Resource Exchange
(AGRE) repository lists 14% and 5% of the individuals
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using the TDT in our study is the lack of total inde-
pendence between the trios analyzed: the 1,510 trios
used in the TDT are part of 1,101 independent nu-
clear families. The correlation among children in the
same family can inflate the type I error probability.
We, thus, also applied the PDT, also a within family
test that is robust to population substructure, and the
PDT analysis corroborates the TDT analysis.
Conclusion
SNPs within the CD99 molecule-like 2 gene, the jumonji
AT rich interactive domain 2 (JARID2) gene, and the
thyroid peroxidase gene were associated with ASD after
multiple comparisons adjustment. Understanding how
these genetic factors might contribute to pathogenesis
should ultimately lead to important opportunities for
discovering therapeutic targets that can be used to treat
ASD.
Additional file
Additional file 1: Table S1. Immune-function genes.
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